- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Achieving
the
End of AIDS
Achieving
the
End of
AIDS
The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:
- Deliver proven tools for immediate impacts.
- Demonstrate and roll out new HIV prevention tools.
- Develop long-term solutions to end the epidemic.
Spotlight
- June 24, 2022
As a global organization dedicated to health as a human right, to social justice, and to individual autonomy and choice, AVAC stands today and always for reproductive justice. We condemn the 6-3 decision by the US Supreme Court, which rolls back decades of protections for those seeking safe abortion services in the US.
- June 22, 2022
For more than a decade, AVAC and partners have been leading Media Science Cafés, a program connecting journalists, researchers and advocates to help expand and deepen accurate reporting of HIV science. The program began in Uganda, when a group of journalists were looking for ways to connect with research and better understand both the science of HIV and its impact on their communities.
- June 13, 2022
Yesterday, Dr. John Nkengasong was sworn-in as the US Global AIDS Coordinator and Special Representative for Global Health Diplomacy overseeing PEPFAR. We are confident that with Ambassador Nkengasong’s ambitious leadership, vision and experience, PEPFAR and the global community can maintain the urgency and impact in ending the AIDS pandemic.
- June 9, 2022
Last month, ViiV Healthcare, the maker of injectable cabotegravir (CAB) announced it is "actively negotiating voluntary licensing terms'' of CAB for PrEP. This comes after advocates demanded that ViiV does its part to make good on the promise of injectable CAB for PrEP to advance HIV prevention.
What We Do
AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more
Px Methods
AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.